Phase III comparison of high-dose paclitaxel + cisplatin + granulocyte colony-stimulating factor versus low-dose paclitaxel + cisplatin in advanced head and neck cancer: Eastern Cooperative Oncology Group Study E1393. [electronic resource]
Producer: 20010412Description: 1088-95 p. digitalISSN:- 0732-183X
- Adult
- Aged
- Agranulocytosis -- chemically induced
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Carcinoma, Squamous Cell -- drug therapy
- Cisplatin -- administration & dosage
- Drug Administration Schedule
- Female
- Granulocyte Colony-Stimulating Factor -- administration & dosage
- Head and Neck Neoplasms -- drug therapy
- Humans
- Male
- Middle Aged
- Neutropenia -- chemically induced
- Paclitaxel -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.